Tuberc Respir Dis.
2024 Apr;87(2):202-205. 10.4046/trd.2023.0120.
Real-World Outcomes of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Pulmonary Disease
- Affiliations
-
- 1Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea
- 2Department of Pulmonary and Critical Care Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Republic of Korea
- 3Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
- KMID: 2553780
- DOI: http://doi.org/10.4046/trd.2023.0120
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Rapid identification of mycobacterium avium and mycobacterium intracellulare by the amplification of rRNA sequences
- Treatment of Mycobacterium avium Complex Pulmonary Disease
- Treatment of Mycobacterium avium complex pulmonary disease
- Treatment of Mycobacterium Abscessus Pulmonary Disease
- Acute pneumonia caused by mycobacterium intracellulare
